PKC412 IN PARTICIPANTS WITH ACUTE MYELOID LEUKEMIA OR WITH MYELODYSPLASTIC SYNDROME (CPKC412A2104 CORE); AND PKC412 IN PARTICIPANTS WITH ACUTE MYELOID LEUKEMIA OR WITH MYELODYSPLASTIC SYNDROME WITH EITHER WILD TYPE OR MUTATED FMS-LIKE TYROSINE KINASE 3 (FLT3) (CPKC412A2104E1 AND CPKC412A2104E2):